**
Recent research has unveiled alarming findings regarding the presence of per- and polyfluoroalkyl substances (Pfas), commonly referred to as ‘forever chemicals,’ in umbilical cord blood. A study conducted by Mount Sinai has demonstrated that fetuses are likely exposed to significantly higher concentrations of these harmful compounds than previously acknowledged. This revelation holds critical implications for public health, particularly concerning the health risks associated with prenatal exposure to Pfas.
Uncovering the Scope of Pfas Exposure
Historically, testing of umbilical cord blood has primarily focused on a limited number of Pfas compounds, such as perfluorooctanoic acid (Pfoa) and perfluorooctane sulfonate (Pfos). However, the Mount Sinai study expanded its approach by employing a non-targeted analysis of 120 umbilical cord blood samples that had previously tested positive for just four compounds. The results were striking: the analysis identified 42 distinct Pfas compounds across the samples, revealing a far broader scope of fetal exposure than previously understood.
Shelley Liu, a co-author of the study and associate professor at the Icahn School of Medicine, emphasised the significance of these findings, stating, “Babies are exposed to many more Pfas than we previously thought.” Liu underscored the vulnerability of fetuses during this critical developmental period, further accentuating the need for comprehensive understanding and action.
Pfas: The ‘Forever Chemicals’ Linked to Health Risks
Pfas comprise a vast class of approximately 15,000 synthetic compounds, widely utilised for their water-, stain-, and grease-resistant properties. The chemicals have been implicated in various health issues, including cancer, developmental disorders, compromised immune systems, and metabolic diseases. Dubbed ‘forever chemicals’ due to their persistence in the environment and human body, they do not break down naturally, leading to cumulative exposure over time.
A thorough review of existing studies found Pfas in 30,000 umbilical cord blood samples, highlighting the pervasive nature of these contaminants. Elevated maternal Pfas levels have been associated with increased risks of infant mortality, low birth weight, and obesity in later life. Furthermore, prenatal exposure has been linked to potential long-term health problems, including cancer and cardiovascular disease.
Regulatory Gaps and the Need for Comprehensive Testing
The legacy compounds Pfoa and Pfos dominated usage until the last decade, but they have since been largely phased out in favour of newer formulations. However, these alternatives often lack rigorous safety evaluations, and chemical manufacturers routinely assert reduced toxicity without substantial evidence. Compounding the issue, the methods employed by regulatory bodies, such as the US Environmental Protection Agency (EPA), have struggled to keep pace with the emergence of new Pfas compounds. The EPA’s standard water testing protocols typically target only 30-40 compounds, while independent studies have identified thousands more in various environments.
The Mount Sinai study effectively juxtaposed the outdated testing methods with a more expansive non-targeted analysis, resulting in the detection of 31 Pfas compounds not included in the EPA’s current testing regime. Liu acknowledged that while the EPA has recently certified a blood test for 53 compounds, the limitations of this approach highlight the urgent need for more comprehensive testing protocols.
Implications for Future Research and Policy
While the Mount Sinai study did not directly assess health outcomes related to the elevated Pfas levels, the correlation between increased blood concentrations and potential health risks remains a pressing concern. The analysed blood samples were sourced from a federal study tracking Pfas exposure and health outcomes over time, indicating that further investigation into the health implications of these findings is both necessary and imminent.
David Andrews, acting chief science officer for the Environmental Working Group, commented on the study’s significance, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as Pfas.”
Why it Matters
The findings from the Mount Sinai study serve as a crucial wake-up call to both policymakers and the public regarding the pervasive presence of Pfas in our environment and its potential impact on fetal health. As the understanding of these chemicals evolves, so too must the regulatory frameworks designed to protect vulnerable populations, particularly expectant mothers and their infants. The urgency for robust, health-protective regulations cannot be overstated, as the implications of inaction could resonate for generations to come.
